NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage...
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage...
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage...
NDA for govorestat accepted and granted Priority Review by FDA for the treatment of Classic Galactosemia; PDUFA...
Financing includes significant participation from a number of large healthcare dedicated institutional and...
PDUFA target action date of August 28, 2024 MAA validated and accepted for review by EMA in December 2023 NEW...
Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.